ResearcherThe University of MelbourneActive in the last 2 years
Arian Ansardamavandi
Matched on ORCID iD 0000-0003-0716-0085; OpenAlex author ID A5015573138. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2023: 1 paper · 2024: none · 2025: 3 papers
Papers 4
- The Effects of PAK-Regulated Tumour Vasculature on Gemcitabine Response of Pancreatic Cancer. Co-author DOI 10.3390/cancers17213434↗
- Targeting PAK1 or PAK4 Uncovers Different Mechanisms of Vascular Reprogramming in Pancreatic Cancer. Co-author DOI 10.3390/cells14221806↗
- P-21 Kinase 1 or 4 Knockout Stimulated Anti-Tumour Immunity Against Pancreatic Cancer by Enhancing Vascular Normalisation. Co-author DOI 10.3390/ijms26178357↗
- PAK in Pancreatic Cancer-Associated Vasculature: Implications for Therapeutic Response. Co-author DOI 10.3390/cells12232692↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hong Zhen He · 4 shared papers, 2023–2025 · strength 1.15
- Paper PAK in Pancreatic Cancer-Associated Vasculature: Implications for Therapeutic Response. DOI 10.3390/cells12232692↗
- Paper Targeting PAK1 or PAK4 Uncovers Different Mechanisms of Vascular Reprogramming in Pancreatic Cancer. DOI 10.3390/cells14221806↗
- Paper The Effects of PAK-Regulated Tumour Vasculature on Gemcitabine Response of Pancreatic Cancer. DOI 10.3390/cancers17213434↗
- Mehrdad Nikfarjam · 4 shared papers, 2023–2025 · strength 1.15
- Paper PAK in Pancreatic Cancer-Associated Vasculature: Implications for Therapeutic Response. DOI 10.3390/cells12232692↗
- Paper Targeting PAK1 or PAK4 Uncovers Different Mechanisms of Vascular Reprogramming in Pancreatic Cancer. DOI 10.3390/cells14221806↗
- Paper The Effects of PAK-Regulated Tumour Vasculature on Gemcitabine Response of Pancreatic Cancer. DOI 10.3390/cancers17213434↗
- Ching‐Seng Ang · 3 shared papers, 2025 · strength 0.84
- Paper Targeting PAK1 or PAK4 Uncovers Different Mechanisms of Vascular Reprogramming in Pancreatic Cancer. DOI 10.3390/cells14221806↗
- Paper The Effects of PAK-Regulated Tumour Vasculature on Gemcitabine Response of Pancreatic Cancer. DOI 10.3390/cancers17213434↗
- Paper P-21 Kinase 1 or 4 Knockout Stimulated Anti-Tumour Immunity Against Pancreatic Cancer by Enhancing Vascular Normalisati… DOI 10.3390/ijms26178357↗
- Yi Ma · 2 shared papers, 2025 · strength 0.54
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.